Cargando…

Effects of 2-bromoterguride, a dopamine D(2) receptor partial agonist, on cognitive dysfunction and social aversion in rats

RATIONALE: 2-Bromoterguride, a dopamine D(2) receptor partial agonist with antagonist properties at serotonin 5-HT(2A) receptors and α(2C)-adrenoceptors, meets the prerequisites of a putative atypical antipsychotic drug (APD). We recently showed that 2-bromoterguride is effective in tests of positiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarland, Emilia, Franke, Robert T., Fink, Heidrun, Pertz, Heinz H., Brosda, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748440/ https://www.ncbi.nlm.nih.gov/pubmed/28971230 http://dx.doi.org/10.1007/s00213-017-4747-x

Ejemplares similares

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
por: Franke, Robert T., et al.
Publicado: (2016)

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment
por: Ersche, Karen D., et al.
Publicado: (2010)

Human cognitive flexibility depends on dopamine D2 receptor signaling
por: van Holstein, Mieke, et al.
Publicado: (2011)

Conscious perception and the modulatory role of dopamine: no effect of the dopamine D2 agonist cabergoline on visual masking, the attentional blink, and probabilistic discrimination
por: Boonstra, E.A, et al.
Publicado: (2020)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

Encoding of Aversion by Dopamine and the Nucleus Accumbens
por: McCutcheon, James E., et al.
Publicado: (2012)

The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion
por: Peczely, Laszlo, et al.
Publicado: (2022)

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
por: Mohr, Pavel, et al.
Publicado: (2022)

Reward and avoidance learning in the context of aversive environments and possible implications for depressive symptoms
por: Sebold, Miriam, et al.
Publicado: (2019)

Discovery research and development history of the dopamine D(2) receptor partial agonists, aripiprazole and brexpiprazole
por: Kikuchi, Tetsuro, et al.
Publicado: (2021)

Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
por: Hart, Xenia M., et al.
Publicado: (2022)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Dopamine receptor agonists modulate voluntary alcohol intake independently of individual levels of alcohol intake in rats
por: Spoelder, Marcia, et al.
Publicado: (2016)

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography
por: Pamukcu, Hilal Erken, et al.
Publicado: (2018)

Behavioural effects of APH199, a selective dopamine D4 receptor agonist, in animal models
por: Chestnykh, Daria, et al.
Publicado: (2023)

An investigation into aripiprazole’s partial D(2) agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers
por: Murphy, Anna, et al.
Publicado: (2016)

The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers
por: McCabe, Ciara, et al.
Publicado: (2011)

The novel atypical antipsychotic cariprazine demonstrates dopamine D(2) receptor‐dependent partial agonist actions on rat mesencephalic dopamine neuronal activity
por: Delcourte, Sarah, et al.
Publicado: (2018)

Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice
por: He, Qing, et al.
Publicado: (2014)

High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?
por: Reynolds, Gavin P
Publicado: (2021)

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
por: Seeman, P
Publicado: (2016)

Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
por: Mandic-Maravic, Vanja, et al.
Publicado: (2022)

Food Deprivation, Body Weight Loss and Anxiety-Related Behavior in Rats
por: Dietze, Silke, et al.
Publicado: (2016)

The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers
por: Lawn, Will, et al.
Publicado: (2018)

Dopamine Signaling in C. elegans Is Mediated in Part by HLH-17-Dependent Regulation of Extracellular Dopamine Levels
por: Felton, Chaquettea M., et al.
Publicado: (2014)

Activation of Dopamine Neurons is Critical for Aversive Conditioning and Prevention of Generalized Anxiety
por: Zweifel, Larry S., et al.
Publicado: (2011)

Three Dopamine Pathways Induce Aversive Odor Memories with Different Stability
por: Aso, Yoshinori, et al.
Publicado: (2012)

Medial prefrontal cortex dopamine controls the persistent storage of aversive memories
por: Gonzalez, María C., et al.
Publicado: (2014)

Roles of dopamine neurons in mediating the prediction error in aversive learning in insects
por: Terao, Kanta, et al.
Publicado: (2017)

Mesolimbic dopamine release precedes actively sought aversive stimuli in mice
por: Yawata, Yosuke, et al.
Publicado: (2023)

Potent and Subtype-Selective Dopamine D(2) Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
por: Mallo-Abreu, Ana, et al.
Publicado: (2021)

Effects of Dopamine D(2) Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-(11)C]DOPA
por: Ito, Hiroshi, et al.
Publicado: (2012)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Cariprazine, A Dopamine D(2)/D(3) Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
por: Hussein, Noor, et al.
Publicado: (2018)

The Role of the Dopamine D2 Receptor in Form-Deprivation Myopia in Mice: Studies With Full and Partial D2 Receptor Agonists and Knockouts
por: Huang, Furong, et al.
Publicado: (2020)

The effects of acute tryptophan depletion on costly information sampling: impulsivity or aversive processing?
por: Crockett, M. J., et al.
Publicado: (2011)

The G‐protein biased partial κ opioid receptor agonist 6′‐GNTI blocks hippocampal paroxysmal discharges without inducing aversion
por: Zangrandi, Luca, et al.
Publicado: (2016)

S37. STATE-DEPENDENT EFFECTS OF D2 PARTIAL AGONIST ARIPIPRAZOLE ON DOPAMINE NEURON ACTIVITY IN THE MAM NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA
por: Sonnenschein, Susan, et al.
Publicado: (2018)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7u3lv3fo886sog1dqvn91nn3r